The CTLA4 variants may interact with the IL23R- and NOD2-conferred risk in development of Crohn's disease

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Hradsky, Ondrej ^a   Dusatkova, Petra ^a   Lenicek, Martin ^b   Bronsky, Jiri ^a   Nevoral, Jiri ^a   Vitek, Libor ^b   Lukas, Milan ^b,c   Zeniskova, Ivana ^d   Cinek, Ondrej ^a  

^a UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ISCARE IVF   (Czech Republic)

^d eské Bud jovice Hospital a s   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 23 RECEPTOR; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CROHN DISEASE; CZECH REPUBLIC; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PATHOGENESIS; POPULATION RESEARCH; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOTOXIC T LYMPHOCYTE; ENTERITIS; GENETIC POLYMORPHISM; GENETICS; RISK FACTOR;

ALLELES; ANTIGENS, CD; CROHN DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATORY BOWEL DISEASES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77953245440     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-91     Document Type: Article

References (33)

1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411(6837):599-603. 10.1038/35079107, 11385576.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411(6837):603-606. 10.1038/35079114, 11385577.
3. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, Kocher K, Miller K, Guschwan S, et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001, 29(2):223-228. 10.1038/ng1001-223, 11586304.
4. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314(5804):1461-1463. 10.1126/science.1135245, 17068223.
5. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007, 39(5):596-604. 10.1038/ng2032, 2757939, 17435756.
6. Hradsky O, Lenicek M, Dusatkova P, Bronsky J, Nevoral J, Valtrova V, Kotalova R, Szitanyi P, Petro R, Starzykova V, et al. Variants of CARD15, TNFA and PTPN22 and susceptibility to Crohn's disease in the Czech population: high frequency of the CARD15 1007fs. Tissue Antigens 2008, 71(6):538-547. 10.1111/j.1399-0039.2008.01047.x, 18489434.
7. Dusatkova P, Hradsky O, Lenicek M, Bronsky J, Nevoral J, Kotalova R, Bajerova K, Vitek L, Lukas M, Cinek O. Association of IL23R p.381Gln and ATG16L1 p.197Ala With Crohn Disease in the Czech Population. J Pediatr Gastroenterol Nutr 2009, 49(4):405-10. 10.1097/MPG.0b013e31819344ee, 19590455.
8. The Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447(7145):661-678. 10.1038/nature05911, 2719288, 17554300, The Wellcome Trust Case Control Consortium.
9. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008, 40(8):955-962. 10.1038/ng.175, 2574810, 18587394.
10. Tremelling M, Parkes M. Genome-wide association scans identify multiple confirmed susceptibility loci for Crohn's disease: lessons for study design. Inflamm Bowel Dis 2007, 13(12):1554-1560. 10.1002/ibd.20239, 17712840.
11. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 2007, 39(7):830-832. 10.1038/ng2061, 2628541, 17554261.
12. Libioulle C, Louis E, Hansoul S, Sandor C, Farnir F, Franchimont D, Vermeire S, Dewit O, de Vos M, Dixon A, et al. Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4. PLoS Genet 2007, 3(4):e58. 10.1371/journal.pgen.0030058, 1853118,1853118, 17447842.
13. Read S, Malmström V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000, 192(2):295-302. 10.1084/jem.192.2.295, 2193261, 10899916.
14. Liu Z, Geboes K, Hellings P, Maerten P, Heremans H, Vandenberghe P, Boon L, van Kooten P, Rutgeerts P, Ceuppens JL. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol 2001, 167(3):1830-1838.
15. van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004, 13(7):763-770. 10.1093/hmg/ddh090, 14976156.
16. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM, Smith AN, Di Genova G, et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003, 423(6939):506-511. 10.1038/nature01621, 12724780.
17. Howson JM, Walker NM, Smyth DJ, Todd JA. Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families. Genes Immun 2009, 10(Suppl 1):S74-84. 10.1038/gene.2009.96, 2810493, 19956106.
18. Xia B, Crusius JB, Wu J, Zwiers A, van Bodegraven AA, Pena AS. CTLA4 gene polymorphisms in Dutch and Chinese patients with inflammatory bowel disease. Scand J Gastroenterol 2002, 37(11):1296-1300. 10.1080/003655202761020579, 12465728.
19. Machida H, Tsukamoto K, Wen CY, Narumi Y, Shikuwa S, Isomoto H, Takeshima F, Mizuta Y, Niikawa N, Murata I, et al. Association of polymorphic alleles of CTLA4 with inflammatory bowel disease in the Japanese. World J Gastroenterol 2005, 11(27):4188-4193.
20. Rueda B, Zhernakova A, Lopez-Nevot MA, Gomez-Garcia M, Ortega E, Pinero A, Correro F, Brieva JA, Nieto A, Koeleman BP, et al. CTLA4/CT60 polymorphism is not relevant in susceptibility to autoimmune inflammatory intestinal disorders. Hum Immunol 2005, 66(3):321-325. 10.1016/j.humimm.2004.11.005, 15784471.
21. Magyari L, Faragó B, Bene J, Horvatovich K, Lakner L, Varga M, Figler M, Gasztonyi B, Mózsik G, Melegh B. No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples. World J Gastroenterol 2007, 13(15):2205-2208.
22. IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis--the Porto criteria. J Pediatr Gastroenterol Nutr 2005, 41(1):1-7. 10.1097/01.MPG.0000163736.30261.82, 15990620, IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition..
23. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl A):5-36.
24. González JR, Armengol L, Solé X, Guinó E, Mercader JM, Estivill X, Moreno V. SNPassoc: an R package to perform whole genome association studies. Bioinformatics 2007, 23(5):644-645. 10.1093/bioinformatics/btm025, 17267436.
25. Armuzzi A, Ahmad T, Ling KL, de Silva A, Cullen S, van Heel D, Orchard TR, Welsh KI, Marshall SE, Jewell DP. Genotype-phenotype analysis of the Crohn's disease susceptibility haplotype on chromosome 5q31. Gut 2003, 52(8):1133-1139. 10.1136/gut.52.8.1133, 1773736, 12865271.
26. Linderson Y, Bresso F, Buentke E, Pettersson S, D'Amato M. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms. Int J Colorectal Dis 2005, 20(4):305-311. 10.1007/s00384-004-0732-z, 15800781.
27. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, Rosenstiel P, Albrecht M, Croucher PJ, Seegert D, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004, 36(5):476-480. 10.1038/ng1345, 15107852.
28. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 2007, 39(2):207-211. 10.1038/ng1954, 17200669.
29. Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, et al. IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease. Am J Gastroenterol 2007, 102(12):2754-2761. 10.1111/j.1572-0241.2007.01525.x, 17894849.
30. Browning BL, Annese V, Barclay ML, Bingham SA, Brand S, Büning C, Castro M, Cucchiara S, Dallapiccola B, Drummond H, et al. Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet 2008, 45(1):36-42. 10.1136/jmg.2007.050773, 17693570.
31. Cummings JR, Ahmad T, Geremia A, Beckly J, Cooney R, Hancock L, Pathan S, Guo C, Cardon LR, Jewell DP. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype. Inflamm Bowel Dis 2007, 13(9):1063-1068. 10.1002/ibd.20180, 17508420.
32. Török HP, Glas J, Endres I, Tonenchi L, Teshome MY, Wetzke M, Klein W, Lohse P, Ochsenkühn T, Folwaczny M, et al. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease. Am J Gastroenterol 2009, 104(7):1723-1733. 10.1038/ajg.2009.184, 19455129.
33. de Ridder L, Weersma RK, Dijkstra G, van der Steege G, Benninga MA, Nolte IM, Taminiau JA, Hommes DW, Stokkers PC. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis 2007, 13(9):1083-1092. 10.1002/ibd.20171, 17476680.